Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain

Abbaszadeh F., Jorjani M., Amirian R., Fakhri S., Khan H.

Clinical Trial on Chronic Inflammation, published in Curr Neuropharmacol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Curr Neuropharmacol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
40611406
PMCID
PMC13269943
DOI
10.2174/011570159x371386250619064416

Abstract (original English)

Chronic pain, characterized by persistent discomfort and reduced quality of life, poses a significant challenge for individuals. Chronic pain is predominantly divided into central neuropathic pain, peripheral neuropathic pain, and inflammatory pain. Considering the multiple dysregulated pathways behind such pain conditions, researchers are exploring new multi-target agents that offer enhanced efficacy and reduced side effects of the present drugs. Carotenoids are natural pigments with antioxidant and anti-inflammatory properties found in various fruits, vegetables, and seafood. Through their mechanisms of action, carotenoids have shown promising efficacy in alleviating pain hypersensitivity, reducing inflammation and oxidative stress, and modulating pain-related signaling pathways. This comprehensive review delves into the potential of carotenoids and their derivatives as natural nutraceuticals for managing inflammation and relieving pain. In the current study, the mechanisms of action by which carotenoids exert their beneficial effects during preclinical and clinical studies are provided. This review could pave the road for the application of carotenoids for more pain-related clinical trials and further applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsHumansPainNeuralgiaInflammationCarotenoidsAnalgesicsAnti-Inflammatory AgentsAntioxidants

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research